These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 8558226)

  • 21. Preserved Axin expression is associated with an aggressive phenotype in invasive breast carcinomas.
    Irini T; Paraskevi A; Ioanna G; Christos P; Lydia N
    APMIS; 2013 Sep; 121(9):797-805. PubMed ID: 23278310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Expression of the c-erbB-2 oncoprotein in mammary Paget's disease. Immunohistochemical study by using 3 antibodies].
    Edorh A; Parache RM; Migeon C; N'Sossani B; Rihn B
    Pathol Biol (Paris); 1995 Sep; 43(7):584-9. PubMed ID: 8570262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAG-1/SODD, HSP70, and HSP90 are potential prognostic markers of poor survival in node-negative breast carcinoma.
    Davidson B; Valborg Reinertsen K; Trinh D; Reed W; Bøhler PJ
    Hum Pathol; 2016 Aug; 54():64-73. PubMed ID: 27038683
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of chromosomal aberrations in breast cancer by comparative genomic hybridization (CGH). Correlation with histoprognostic variables and c-erbB-2 immunoexpression.
    Malamou-Mitsi VD; Syrrou M; Georgiou I; Pagoulatos G; Agnantis NJ
    J Exp Clin Cancer Res; 1999 Sep; 18(3):357-61. PubMed ID: 10606182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer.
    Eggemann H; Ignatov T; Burger E; Kantelhardt EJ; Fettke F; Thomssen C; Costa SD; Ignatov A
    Endocr Relat Cancer; 2015 Oct; 22(5):725-33. PubMed ID: 26187126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymphocytic infiltrate is associated with favorable biomarkers profile in HER2-overexpressing breast cancers and adverse biomarker profile in ER-positive breast cancers.
    Tsang JY; Hui SW; Ni YB; Chan SK; Yamaguchi R; Kwong A; Law BK; Tse GM
    Breast Cancer Res Treat; 2014 Jan; 143(1):1-9. PubMed ID: 24272079
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutual predictive value of c-erbB-2 overexpression and various prognostic factors in ductal invasive breast carcinoma.
    Jakić-Razumović J; Petrovecki M; Uzarević B; Gamulin S
    Tumori; 2000; 86(1):30-6. PubMed ID: 10778763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of neoadjuvant chemotherapy on pathologic axillary nodal status in HER-2 positive patients presenting with clinically node-negative disease.
    Al-Hilli Z; Hieken TJ; Hoskin TL; Heins CN; Boughey JC
    J Surg Oncol; 2015 Oct; 112(5):453-7. PubMed ID: 26345596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-associated lymphocytes and macrophages are related to stromal elastosis and vascular invasion in breast cancer.
    Chen Y; Klingen TA; Aas H; Wik E; Akslen LA
    J Pathol Clin Res; 2021 Sep; 7(5):517-527. PubMed ID: 34076969
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiogenesis, p53, and c-erbB-2 immunoreactivity and clinicopathological features in male breast cancer.
    Shpitz B; Bomstein Y; Sternberg A; Klein E; Liverant S; Groisman G; Bernheim J
    J Surg Oncol; 2000 Dec; 75(4):252-7. PubMed ID: 11135266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered expression of HLA class I antigens in breast cancer: association with prognosis.
    Gudmundsdóttir I; Gunnlaugur Jónasson J; Sigurdsson H; Olafsdóttir K; Tryggvadóttir L; Ogmundsdóttir HM
    Int J Cancer; 2000 Nov; 89(6):500-5. PubMed ID: 11102894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lack of prognostic significance of "classic" lobular breast carcinoma: a matched, single institution series.
    Viale G; Rotmensz N; Maisonneuve P; Orvieto E; Maiorano E; Galimberti V; Luini A; Colleoni M; Goldhirsch A; Coates AS
    Breast Cancer Res Treat; 2009 Sep; 117(1):211-4. PubMed ID: 18629634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced humoral immunity in breast cancer patients with high serum concentration of anti-HER2 autoantibody.
    Sato Y; Shimoda M; Sota Y; Miyake T; Tanei T; Kagara N; Naoi Y; Kim SJ; Noguchi S; Shimazu K
    Cancer Med; 2021 Feb; 10(4):1418-1430. PubMed ID: 33506656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.
    Milde-Langosch K; Karn T; Müller V; Witzel I; Rody A; Schmidt M; Wirtz RM
    Breast Cancer Res Treat; 2013 Jan; 137(1):57-67. PubMed ID: 23135572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic role of immune infiltrates in breast ductal carcinoma in situ.
    Chen XY; Yeong J; Thike AA; Bay BH; Tan PH
    Breast Cancer Res Treat; 2019 Aug; 177(1):17-27. PubMed ID: 31134489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer.
    Mohammed ZM; Going JJ; Edwards J; Elsberger B; McMillan DC
    Br J Cancer; 2013 Sep; 109(6):1676-84. PubMed ID: 23982600
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ESPL1 is a candidate oncogene of luminal B breast cancers.
    Finetti P; Guille A; Adelaide J; Birnbaum D; Chaffanet M; Bertucci F
    Breast Cancer Res Treat; 2014 Aug; 147(1):51-9. PubMed ID: 25086634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of CD44 variant v6 in breast carcinoma and its relationship with other parameters of tumor biology].
    Aceituno E; Turrión F; San Román JM; Sarasa JL; Ortiz F; García R
    Med Clin (Barc); 1998 Jul; 111(5):168-71. PubMed ID: 9732832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of Bcl-2 in invasive mammary carcinomas: a comparative clinicopathologic study between "triple-negative" and non-"triple-negative" tumors.
    Tawfik K; Kimler BF; Davis MK; Fan F; Tawfik O
    Hum Pathol; 2012 Jan; 43(1):23-30. PubMed ID: 21777944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas.
    Iwamoto M; Shinohara H; Miyamoto A; Okuzawa M; Mabuchi H; Nohara T; Gon G; Toyoda M; Tanigawa N
    Int J Cancer; 2003 Mar; 104(1):92-7. PubMed ID: 12532424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.